On the other hand, augmented GRK2 levels have been reported in peripheral blood samples in HF (Rengo et al., 2016) or acute myocardial infarction (Santulli et al., 2011) patients, but the potential pathophysiological impact of such altered dosage remains to be determined. The gene discussed is GRK2; the disease is hydrops fetalis.